Navigation Links
James T. Glover Appointed to Board of Directors of Varian, Inc.
Date:5/7/2008

PALO ALTO, Calif., May 7 /PRNewswire-FirstCall/ Varian, Inc. (NasdaqGS: VARI) announced that its Board of Directors today appointed James T. Glover as a new director. Glover is the seventh member of Varian, Inc.'s board of directors, and was appointed for a term expiring at the annual meeting of the Company's stockholders in 2009.

Glover is Senior Vice President, Operations and Chief Financial Officer of Anadys Pharmaceuticals, Inc. (a biopharmaceutical company), a position he has held since 2006. Before that, from 2003 to 2006, he was Senior Vice President and Chief Financial Officer of Beckman Coulter, Inc. (a biomedical testing instruments company), where he held a variety of other finance-related positions from 1989 to 2003.

"We are very pleased to have Jim Glover as a member of the Varian, Inc. board," said Allen J. Lauer, Chairman of the Board, Varian, Inc. "His exceptional background in finance and accounting, combined with his extensive laboratory instruments and life science industry experience, will serve us well in both protecting and promoting stockholder value."

Glover earned his Bachelor of Science degree in accounting from California State Polytechnic University, Pomona, and an MBA from Pepperdine University. He is a certified public accountant and former audit manager with KPMG International.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 4,000 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further i
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
2. Orchid Cellmark Appoints James F. Smith Chief Financial Officer
3. Immunotec Inc. announces appointment of President & CEO James A. Northrop
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. James Webb Space Telescope marks successful completion
6. IRIDEX Announces James Mackaness Will Be Chief Financial Officer
7. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
8. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
9. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
10. Warner Chilcott Reports the Death of Its Director James Andress
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
....,(NasdaqGS: VARI) today announced that Garry W. R...q OMX 22nd Investor Program in London on Thursday,... A live webcast of the presentation will be publi...://www.varianinc.com . Go to http://www.varianin...ay will be available to the public,from Varian, In...
... marketing research,leader in pain, announces resu...g Company Survey". The top three most appreciated...ticals, according to the 100 pain clinic,physician... most noted for,their knowledgeable, respectful an...oucher plans, and their educational resources, as ...
...Innovations, LLC, a subsidiary of Wound Management...ished case demonstrating the efficacy of their adv... The case was presented in the,November/December ...ection,Diabetic Wound Care Management on the Leadi... #1: Using Combined Treatment Modalities for Succe...
Other Biology Technology:WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 1Taking dex can improve high altitude exercise capacity in certain climbers 54225 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 3Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 1Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 2Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 3World Stem Cell Summit to Be Held in Baltimore 13504 1World Stem Cell Summit to Be Held in Baltimore 13504 2
...es may prevent recovering drug abusers from relaps...ve discovered., The team, led by Professor Barry E... in rats by blocking a brain chemical receptor imp... drug-associated memories. Their research, which ...ported in the 13 August issue of The Journal of N...
...2 AUGUST 2008 -- More than 10,000 international sc...ill gather at the George R. Brown Convention Cente...test research and trends in energy, water resource... earth sciences, and related disciplines. , This ... that showcases the sciences of the sponsoring org...
...performance of different types of green roofs has ... Center at The University of Texas at Austin and s...re created equal. , Interest in vegetated roofs h...mes more important to property owners. Yet the stu...the green roofs varied greatly in capabilities suc...
Other Biology News:'Erasing' drug-associated memories may stop drug addiction relapses 2Scientists team up in Houston to tackle global challenges 2Scientists team up in Houston to tackle global challenges 3Scientists team up in Houston to tackle global challenges 4Green roofs differ in building cooling, water handling capabilities 2Green roofs differ in building cooling, water handling capabilities 3
...ntials Kit provides all the necessary materials an...n washing of the mir Vana miRNA Bioarrays when us...g Ambions mir Vana miRNA Labeling Kit. The kit al...BA10001) that should be spiked into your miRNA pre...
...ellular Localization Kit provides a straight forwa...f your design, in an efficient yet non-destructive...lular localization and functional inhibition of ta...troduction of the labeled siRNA into mammalian cel...
...ellular Localization Kit provides a straight forwa...f your design, in an efficient yet non-destructive...lular localization and functional inhibition of ta...troduction of the labeled siRNA into mammalian cel...
...ellular Localization Kit with TransIT-siQUEST Tran...ach to directly label and deliver siRNA, of your d... for in vitro tracking experiments. Subcellular lo...e expression can be monitored following introducti...
Biology Products: